UB Paderborn / Katalog / Suche / in CDI

Le lambeau «cerf-volant» dans la reconstruction après exérèse de carcinome baso-cellulaire de la face: notre expérience à propos de 45 cas

Revue de stomatologie et de chirurgie maxillo-faciale, 1989, Vol.90 (5), p.345-348

1989

Link zum Volltext

Verfügbarkeit prüfen

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

The New England journal of medicine, 2021-04, Vol.384 (16), p.1529-1541

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Annals of oncology, 2016-04, Vol.27 (4), p.619-624

2016

Link zum Volltext

Verfügbarkeit prüfen

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

Annals of oncology, 2021-09, Vol.32 (9), p.1148-1156

2021

Link zum Volltext

Verfügbarkeit prüfen

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

Journal of clinical oncology, 2022-10, Vol.40 (28), p.3246-3256

2022

Link zum Volltext

Verfügbarkeit prüfen

Surgical treatment of basocellular carcinoma of the auricular concha. Our experiences apropos of 11 cases

Revue de stomatologie et de chirurgie maxillo-faciale, 1990, Vol.91 (6), p.457-462

1990

Link zum Volltext

Verfügbarkeit prüfen

First-in-human, first-in-class study of the CD44v6 inhibitor AMC303 as monotherapy in patients with advanced epithelial tumors

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii134

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility of complex multi-platform profiling in metastatic cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii480-viii480

2018

Link zum Volltext

Verfügbarkeit prüfen

The "kite" flap in the reconstruction after excision of a basal cell carcinoma of the face. Our experience with 45 cases

Revue de stomatologie et de chirurgie maxillo-faciale, 1989, Vol.90 (5), p.345-348

1989

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging

Breast cancer research : BCR, 2020-09, Vol.22 (1), p.1-11, Article 97

2020

Link zum Volltext

Verfügbarkeit prüfen

Lucitanib for the treatment of HR+ HER2- metastatic breast cancer (MBC) patients (pts): Results from the multicohort phase II FINESSE trial

Annals of oncology, 2018-10, Vol.29, p.viii93-viii93

2018

Link zum Volltext

Verfügbarkeit prüfen

Bowenoid papulosis. Demonstration of human papillomavirus (HPV) with anti-HPV immune serum

Archives of dermatology (1960), 1984-04, Vol.120 (4), p.514

1984

Link zum Volltext

Verfügbarkeit prüfen

The AURORA initiative for metastatic breast cancer

British journal of cancer, 2014-11, Vol.111 (10), p.1881-1887

2014

Link zum Volltext

Verfügbarkeit prüfen

A first-in-class, first-in-human phase I/IIa trial of CAN04, targeting interleukin-1 receptor accessory protein (IL1RAP), in patients with solid tumors

Annals of oncology, 2018-10, Vol.29, p.viii418-viii418

2018

Link zum Volltext

Verfügbarkeit prüfen

Human and Mouse Mutations in WDR35 Cause Short-Rib Polydactyly Syndromes Due to Abnormal Ciliogenesis

American journal of human genetics, 2011-04, Vol.88 (4), p.508-515

2011

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the pre-replication complex cause Meier-Gorlin syndrome

Nature genetics, 2011-04, Vol.43 (4), p.356-359

2011

Link zum Volltext

Verfügbarkeit prüfen

201P Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study

Annals of oncology, 2023-10, Vol.34, p.S262-S262

2023

Link zum Volltext

Verfügbarkeit prüfen

152P Efficacy of olaparib in advanced cancers with germline or somatic tumor mutations in BRCA1, BRCA2, CHEK2 and ATM: A Belgian precision tumor-agnostic phase II study

Annals of oncology, 2023-10, Vol.34, p.S242-S242

2023

Link zum Volltext

Verfügbarkeit prüfen

Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen

Human molecular genetics, 2013-01, Vol.22 (1), p.1-17

2013

Link zum Volltext

Verfügbarkeit prüfen

SYNERGY: Phase I and randomized phase II trial to investigate the addition of the anti-CD73 antibody oleclumab to durvalumab, paclitaxel and carboplatin for previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC)

Annals of oncology, 2019-05, Vol.30, p.iii62-iii62

2019

Link zum Volltext

Verfügbarkeit prüfen

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

Cancer discovery, 2021-11, Vol.11 (11), p.2796-2811

2021

Link zum Volltext

Verfügbarkeit prüfen

First live birth after uterus transplantation in the Middle East

Middle East Fertility Society journal, 2020-10, Vol.25 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

First report of AURORA, the breast international group (BIG) molecular screening initiative for metastatic breast cancer (MBC) patients (pts)

Annals of oncology, 2019-05, Vol.30, p.iii48-iii48

2019

Link zum Volltext

Verfügbarkeit prüfen

179TiP EMERALD: A randomized, open-label, phase III trial to evaluate the efficacy and safety of elacestrant (RAD1901), a novel oral selective estrogen receptor degrader (SERD), vs investigator’s choice of endocrine therapy for ER+/HER2- advanced breast cancer following CDK4/6 inhibitor therapy

Annals of oncology, 2020-05, Vol.31, p.S80-S80

2020

Link zum Volltext

Verfügbarkeit prüfen

O-GlcNAc transferase missense mutations linked to X-linked intellectual disability deregulate genes involved in cell fate determination and signaling

The Journal of biological chemistry, 2018-07, Vol.293 (27), p.10810-10824

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Le lambeau «cerf-volant» dans la reconstruction après exérèse de carcinome baso-cellulaire de la face: notre expérience à propos de 45 cas

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

Surgical treatment of basocellular carcinoma of the auricular concha. Our experiences apropos of 11 cases

First-in-human, first-in-class study of the CD44v6 inhibitor AMC303 as monotherapy in patients with advanced epithelial tumors

Clinical utility of complex multi-platform profiling in metastatic cancer patients

The "kite" flap in the reconstruction after excision of a basal cell carcinoma of the face. Our experience with 45 cases

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging

Lucitanib for the treatment of HR+ HER2- metastatic breast cancer (MBC) patients (pts): Results from the multicohort phase II FINESSE trial

Bowenoid papulosis. Demonstration of human papillomavirus (HPV) with anti-HPV immune serum

The AURORA initiative for metastatic breast cancer

A first-in-class, first-in-human phase I/IIa trial of CAN04, targeting interleukin-1 receptor accessory protein (IL1RAP), in patients with solid tumors

Human and Mouse Mutations in WDR35 Cause Short-Rib Polydactyly Syndromes Due to Abnormal Ciliogenesis

Mutations in the pre-replication complex cause Meier-Gorlin syndrome

201P Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study

152P Efficacy of olaparib in advanced cancers with germline or somatic tumor mutations in BRCA1, BRCA2, CHEK2 and ATM: A Belgian precision tumor-agnostic phase II study

Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen

SYNERGY: Phase I and randomized phase II trial to investigate the addition of the anti-CD73 antibody oleclumab to durvalumab, paclitaxel and carboplatin for previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC)

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

First live birth after uterus transplantation in the Middle East

First report of AURORA, the breast international group (BIG) molecular screening initiative for metastatic breast cancer (MBC) patients (pts)

179TiP EMERALD: A randomized, open-label, phase III trial to evaluate the efficacy and safety of elacestrant (RAD1901), a novel oral selective estrogen receptor degrader (SERD), vs investigator’s choice of endocrine therapy for ER+/HER2- advanced breast cancer following CDK4/6 inhibitor therapy

O-GlcNAc transferase missense mutations linked to X-linked intellectual disability deregulate genes involved in cell fate determination and signaling

Suchergebnisse filtern